Telomir Pharmaceuticals Inc
TELO
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.59M
Close$
$0.22
82.8% downside
Current Fair Value
82.8% downsideOvervalued by 82.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.59 Million |
|---|---|
| Enterprise Value | $79.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | -0.25 |
| Outstanding Shares | 34,380,971 |
Return
| Return on Equity | -116.74% |
|---|---|
| Return on Assets | -109.51% |
| Return on Invested Capital | -120.00% |
Valuation & Multiples
| P/E Ratio | -0.81 |
|---|---|
| PEG | 1.23 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -13.15 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$500,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.62%▲ 2.11% |
|---|---|
| Total Invested | $3.80M▲ 30.29% |
| Investors Holding | 32▲ 5.00% |
ESG Score
No data